ArticleJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2025
Efficacy of leadless left ventricular endocardial stimulation for non-responders to cardiac resynchronization therapy.
Article in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundNon-responders to conventional coronary sinus CRT represent a high-risk heart failure population with limited treatment options. Leadless LV endocardial pacing may provide benefit by delivering more physiological activation patterns, and enabling pacing from optimized LV cavity sites. We aimed to evaluate the efficacy of leadless endocardial pacing using the WiSE-CRT system in CRT non-responders.
methodsA pooled patient-level post-hoc analysis of the SELECT-LV study, the WiSE Post-Market Registry and the SOLVE-CRT trial was performed. Multivariable regression analysis identified predictors of response to WiSE-CRT, followed by ROC analysis and subgroup analysis by degree of QRS narrowing.
resultsThe total cohort comprised of 71 patients. Complete echocardiographic data was available in 66 patients, and complete ECG data available in 45 patients. The clinical response rate (improvement in at least one NYHA class) was 46%. The "combined echocardiographic response rate" (composite of reduction in LV end-systolic volume of ≥15% or improvement in LV ejection fraction of ≥5%) was 51%. The degree of QRS reduction with WiSE-CRT compared to standard CRT was an independent predictor of combined echocardiographic response. ROC analysis generated an AUC of 0.68, with a Youden index cut-off of 19ms reduction in QRS. Subgroup analysis revealed a combined echocardiographic response rate of 70.5% above the cut-off and 38.5% below p = 0.04).
conclusionLeadless endocardial CRT is a viable treatment option for conventional CRT non-responders. The degree of QRS narrowing with LV endocardial stimulation is predictive of response. Optimizing QRS reduction when testing LV pacing sites may be beneficial in maximizing outcomes.
Indexed as
Identifiers
41085945What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.